TRIDIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tridil, and when can generic versions of Tridil launch?
Tridil is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in TRIDIL is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tridil
A generic version of TRIDIL was approved as nitroglycerin by AM REGENT on May 24th, 1988.
Summary for TRIDIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 36 |
Clinical Trials: | 3 |
Patent Applications: | 1,784 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TRIDIL at DailyMed |
Recent Clinical Trials for TRIDIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Cairo University | Early Phase 1 |
Instituto de Cardiologia de Santa Catarina | Phase 3 |
US Patents and Regulatory Information for TRIDIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | TRIDIL | nitroglycerin | INJECTABLE;INJECTION | 018537-002 | Jun 16, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | TRIDIL | nitroglycerin | INJECTABLE;INJECTION | 018537-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |